Randomized Trial With an Observational Component of Non-operative Versus Operative Treatment for AO Type A3 Fractures
Radiographic and Clinical Outcomes Following Non-operative Versus Operative Treatment of AO Type A3 Fractures: A Prospective, Randomized Clinical Trial With an Observational Component
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to compare surgery plus bracing versus bracing alone. Both groups are considered standard of care treatments. The goal of this study is to determine which group is a better treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 16, 2014
CompletedFirst Posted
Study publicly available on registry
July 2, 2014
CompletedStudy Start
First participant enrolled
August 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedJanuary 18, 2017
January 1, 2017
2.8 years
June 16, 2014
January 14, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compare radiologic outcomes using regional kyphosis and Evaluate clinical outcomes using questionnaires
Primary Outcome is to compare radiologic and clinical outcomes. These will be measured by regional kyphosis, at 2 years following either non-operative or operative management of thoracolumbar AO type A3.1, A3.2, A3.3 fractures in neurologically-intact patients; and Oswestry Disability Index, at 2 years following either non-operative or operative management of thoracolumbar AO type A3.1, A3.2, A3.3 fractures in neurologically-intact patients.
2 years
Secondary Outcomes (6)
Compare radiologic outcomes using regional kyphosis
5 and 10 years
Evaluate clinical outcomes using questionnaires
5 and 10 years
Compare global sagittal balance at 3 different time points
2,5, and 10 years
Collect data on patient in both groups for 10 years
10 years
Compare Return to work rates over a two year peiord
3 month, 1 year, and 2 years
- +1 more secondary outcomes
Study Arms (2)
Surgery + Bracing vs. Bracing Alone
ACTIVE COMPARATORRandomize between 2 treatments: Treatment 1: Surgery + Bracing Treatment 2: Bracing alone
Patient's choice
OTHERPatient will decide which group is best for him/her. The patient will be followed at the same points as Group 1.
Interventions
Patient chooses between surgery plus bracing or bracing alone. The patient will be followed according to the same schedule as Group 1.
Surgery + Bracing vs. Bracing Alone
Eligibility Criteria
You may qualify if:
- Age 18-65 years
- Acute trauma patient with AO Type A3.1-A3.3 fractures of T10-L2
- Neurologically intact
- TLICS score of 4
- Women of childbearing potential must have a negative serum pregnancy test
You may not qualify if:
- Severe poly-trauma (Injury Severity Score \>15 and/or intubation required for \> 24 hours)
- Sepsis and/or organ failure
- Prior instrumented arthrodesis of the thoracolumbar spine
- Severe co-morbidities (e.g., heart, respiratory, or renal disease)
- Recent history (\<3 years) of concomitant spinal tumor or infection
- Greater than single level fracture involvement (other than transverse process fractures)
- AO Type A3 fracture with associated load sharing score ≥7
- ≥ 30 degrees regional kyphosis on standing
- History of autoimmune (seronegative) spondyloarthropathy (i.e., ankylosing spondylitis)
- History of osteoporosis
- Subjects who are pregnant or plan to become pregnant in the next 24 months. Patients will be advised on the use of contraceptives during this time. Methods include abstinence or two acceptable forms including condoms with spermicide, birth control pills, injections, or an IUD.
- Co-morbidity requiring medication that may interfere with bone or soft tissue healing (i.e., oral or parenteral glucocorticoids, NSAIDs immunosuppressive agents, methotrexate)
- Severe morbid obesity (BMI \> 40)
- History of metal sensitivity/foreign body sensitivity
- History of prior laminectomy at the fracture site
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ohio State Unviersity
Columbus, Ohio, 43210, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francis Frahadi, MD, PhD
Ohio State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 16, 2014
First Posted
July 2, 2014
Study Start
August 1, 2014
Primary Completion
June 1, 2017
Study Completion
June 1, 2018
Last Updated
January 18, 2017
Record last verified: 2017-01